Grace Y. Zhang, Krupa Patel, Olufunso Agbalajobi, Wheytnie Alexandre, A. Reid, M. Serper, Linda Calgaro, S. Zickmund, Tami Coppler, Margaret Mizah, O. Shaikh, Shari S. Rogal
{"title":"退伍军人对丙型肝炎病毒治疗依从性的看法","authors":"Grace Y. Zhang, Krupa Patel, Olufunso Agbalajobi, Wheytnie Alexandre, A. Reid, M. Serper, Linda Calgaro, S. Zickmund, Tami Coppler, Margaret Mizah, O. Shaikh, Shari S. Rogal","doi":"10.1002/ygh2.474","DOIUrl":null,"url":null,"abstract":"Treatment adherence remains a potential barrier to achieving population‐level hepatitis C virus (HCV) elimination by 2030. We aimed to understand barriers to and facilitators of HCV treatment adherence pre‐ and post‐direct‐acting antiviral (DAA) treatment.","PeriodicalId":12480,"journal":{"name":"GastroHep","volume":"32 1","pages":"307 - 325"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Patient perceptions of successful hepatitis C virus treatment adherence in Veterans\",\"authors\":\"Grace Y. Zhang, Krupa Patel, Olufunso Agbalajobi, Wheytnie Alexandre, A. Reid, M. Serper, Linda Calgaro, S. Zickmund, Tami Coppler, Margaret Mizah, O. Shaikh, Shari S. Rogal\",\"doi\":\"10.1002/ygh2.474\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Treatment adherence remains a potential barrier to achieving population‐level hepatitis C virus (HCV) elimination by 2030. We aimed to understand barriers to and facilitators of HCV treatment adherence pre‐ and post‐direct‐acting antiviral (DAA) treatment.\",\"PeriodicalId\":12480,\"journal\":{\"name\":\"GastroHep\",\"volume\":\"32 1\",\"pages\":\"307 - 325\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"GastroHep\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/ygh2.474\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"GastroHep","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/ygh2.474","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Patient perceptions of successful hepatitis C virus treatment adherence in Veterans
Treatment adherence remains a potential barrier to achieving population‐level hepatitis C virus (HCV) elimination by 2030. We aimed to understand barriers to and facilitators of HCV treatment adherence pre‐ and post‐direct‐acting antiviral (DAA) treatment.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
